Specialty pharmacy accreditation isn’t a state licensing requirement in most places — but try getting into a major payer’s specialty network without it and you’ll find out fast that it’s functionally mandatory. Understanding how accreditation, state licensing, and payer credentialing fit together saves a lot of wasted effort for pharmacies expanding into specialty dispensing.
Accreditation is not the same as licensure
This is the most common confusion. Your state pharmacy license authorizes you to dispense medication in that state, full stop. URAC and ACHC accreditation are voluntary, private, third-party credentialing programs that verify your pharmacy meets specific operational, clinical, and safety standards beyond the baseline state license. No state currently requires specialty pharmacy accreditation as a condition of licensure.
What accreditation actually gates is payer network access. Most major PBMs and specialty drug manufacturers restrict which pharmacies can dispense high-cost specialty medications (biologics, oncology drugs, specialty injectables) to accredited pharmacies within “limited distribution drug” (LDD) networks. Without accreditation, a pharmacy can be legally licensed to dispense a drug and still be contractually locked out of dispensing it because the manufacturer’s distribution agreement requires accredited status.
URAC vs. ACHC: what’s actually different
URAC Specialty Pharmacy Accreditation focuses heavily on:
- Patient management and clinical outcomes documentation
- Care coordination between prescriber, patient, and pharmacy
- Medication therapy management processes specific to complex specialty regimens
- Extensive policy and procedure documentation, often viewed as the more rigorous (and more expensive) of the two paths
ACHC Specialty Pharmacy Accreditation is generally viewed as more operationally focused, with standards covering:
- Dispensing accuracy and safety systems
- Storage, handling, and shipping requirements specific to specialty drugs (many require cold-chain management)
- Patient adherence and financial assistance support
Both accrediting bodies require an on-site (or remote, depending on current survey methodology) audit, a substantial self-assessment application, and ongoing compliance monitoring through the accreditation cycle — typically three years, with interim reporting requirements. Neither accreditor supersedes the other in payer eyes; some payer networks explicitly require one over the other, some accept either, so check the specific payer contracts you’re pursuing before choosing which accreditation to pursue first.
Where state licensing still matters
Even though accreditation is private and voluntary, state law still governs the underlying dispensing activity, and specialty pharmacies face a few state-specific wrinkles more acutely than general retail:
- Non-resident pharmacy licensing — Specialty pharmacies frequently ship nationwide from a centralized facility, which means non-resident pharmacy licensing in every state they ship into, not just their home state. This is one of the most commonly missed compliance gaps when a specialty pharmacy scales quickly.
- Central fill and remote verification — Many specialty operations centralize dispensing and use remote pharmacist verification across sites, which some states regulate distinctly from standard remote order entry.
- 340B compliance overlap — Specialty pharmacies operating as contract pharmacies for 340B covered entities layer 340B program compliance requirements on top of accreditation and licensing — three separate compliance frameworks operating simultaneously on the same prescription.
Preparing for an accreditation survey
Regardless of which accreditor you choose, a few preparation steps consistently matter:
- Start the policy and procedure manual early — Both URAC and ACHC applications require extensive written P&Ps covering patient intake, adherence monitoring, adverse event reporting, and staff competency validation. Building this from scratch during the application window is the most common cause of delayed surveys.
- Audit your pharmacist and technician credentialing files — Accreditors verify staff licensure status, and gaps here (expired licenses, missing CE documentation) are common survey findings. This is a good moment to confirm your team’s CE requirements are current across every state you operate in.
- Map your non-resident licensing footprint — Before applying, confirm you hold active non-resident licenses in every state you intend to ship specialty medication into; accreditors and payers both check this.
- Budget for the full cycle, not just year one — Both accreditors require interim reporting and reaccreditation, and payer contracts often reference “accreditation in good standing” as an ongoing condition, not a one-time checkbox.
Accreditation standards and payer requirements change relatively often — always confirm current URAC and ACHC standards directly with the accrediting body, and verify state licensing obligations with each state board of pharmacy where you plan to dispense.
RxByState tracks non-resident licensing, renewal, and compliance requirements across all 50 states — the licensing foundation every specialty pharmacy accreditation sits on top of. Start a free 14-day trial →